Dapansutrile (Standard)

(Synonyms: OLT1177 (Standard))

Dapansutrile (Standard) (OLT1177 (Standard)) is the analytical standard of Dapansutrile (HY-17629). This product is intended for research and analytical applications. Dapansutrile (OLT1177) is an orally active NLRP3 inhibitor with blood-brain barrier permeability and anti-inflammatory activity. Dapansutrile inhibits NLRP3 ATPase activity, prevents NLRP3-ASC/caspase-1 binding and inflammasome assembly, and reduces IL-1β maturation and pyroptosis. Dapansutrile reduces hepatic JNK, p38 MAPK, and NF-κB-p65 signaling, and decreases TNF-α, IL-6, and oxidative stress. Dapansutrile reduces spinal cord pro-inflammatory cytokines and immune cell infiltration. Dapansutrile enhances glucose-stimulated insulin secretion and calcium influx, promotes insulin vesicle maturation and fusion, and improves mitochondrial function and glucose metabolism. Dapansutrile can be used in research related to various diseases such as neurodegenerative diseases, myocardial ischemia, diabetes, experimental autoimmune encephalomyelitis, and gouty arthritis.

For research use only. We do not sell to patients.

  • Purity : 98%
  • CAS No.: 54863-37-5
  • Formula: C4H7NO2S
  • Molecular Weight:133.17
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Product Information
  • Chemical Information
  • Purity & Documentation
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00